Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

H&H raises full-year forecast after strong H1 growth – shares climb 20%

H&H reported comparable revenue growth of 23.7% in H1 2026 and an adjusted EBITDA margin of 21.8%, driven by broad growth in adult, baby and pet nutrition. The company raised its guidance for revenue, EBITDA and net profit margins for 2026, reduced gross debt by RMB 1bn and announced an interim dividend of 0.82 HKD. Net gearing was 2.05x as of June 30; cash and cash equivalents were around RMB 2bn. Remaining risks include fair-value losses on derivatives, a tax dispute with the Australian authority, higher input costs and the still ongoing turnaround at Solid Gold. » More on de.investing.com
Health and Happiness achieves 34.4% revenue jump in Q1 2026

Health and Happiness reports a 34.4% revenue increase in Q1 2026 to 4.26 billion RMB, driven mainly by its dietary supplements business, which accounts for 60% of sales. The company reports 2.1 billion RMB in cash, reduced gross debt by 300 million RMB during the quarter and aims to cut at least 700 million RMB in 2026. Management cites cross-border e‑commerce (growth +37.3%), new retail formats and one-off effects as drivers; the stock closed up 1.16% and a dividend of around 200 million RMB is planned. » More on de.investing.com
H&H Group records strong growth in revenue and profit in H2 2025

H&H Group reports a solid operating performance for the second half of 2025: annual revenue rose 10.3% to 14.3 billion RMB, net profit increased 22.7% and the adjusted EBITDA margin was 14.3%. The company announced a payout ratio of 30% and a dividend of 0.35 HKD per share; net debt fell by 603 million HKD. Management cited investments in the supply chain and product innovation as growth drivers; H&H expects EPS of 0.17 USD for 2026 and 0.22 USD for 2027, and revenue forecasts of 2.28 billion USD and 2.36 billion USD, respectively. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Health and Happiness (H&H) Int Aktie has already paid €0.11 in dividends. The last payout was in October.

Financials

In the last quarter, Health and Happiness (H&H) Int Aktie had revenue of €1.12bn and net profit of €78.75m

(EUR)	June 2026	YoY
Revenue	1.12bn	-
Gross profit	733.32m	-
Net profit	78.75m	-
EBITDA	243.54m	-

Fundamentals

Metric	Value
Market capitalization	€1.84bn
Number of shares	645.56m
52-week high/low	€2.97 - €1.16
Dividend yield	3.92%
Dividends TTM	€0.11
Beta	1.31
P/E ratio	18.40
PEG ratio	0.02
P/B ratio	2.09
P/S ratio	0.85

Company profile

Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.